Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing
Podcast Image

Vital Health Podcast

Science

Activity Overview

Episode publication activity over the past year

Episodes

Showing 101-113 of 113
«« ← Prev Page 2 of 2

NCATS’ Chris Austin - R&D from NIH, to Industry, through Approval

20 Jul 2021

Contributed by Lukas

After nearly two decades at the NIH and almost 10 years as founding director of the National Center for Advancing Translational Sciences (NCATS), Chri...

About the NIH, Industry, and the R&D Ecosystem, with Richard Moscicki, PhRMA

08 Jul 2021

Contributed by Lukas

Richard Moscicki is the Executive Vice President for Science and Regulatory Advocacy and the Chief Medical Officer at Pharmaceutical Research and Manu...

Jack Scannell on Big Pharma’s Big Drug Discovery Problem

17 Jun 2021

Contributed by Lukas

Jack Scannell is one of the world’s leading pharmaceutical industry analysts, as well as one of its most visionary. Jack caused a case of global pha...

Is U.S. reference pricing a fatal shot for biotech?

05 May 2021

Contributed by Lukas

Drug pricing is becoming a hot political issue in Washington DC, with polls showing widespread bipartisan support for congressional action to control ...

KU Leuven Launches Health Innovation Fellowship

11 Mar 2021

Contributed by Lukas

While not featured in Hollywood blockbuster films like some universities from the UK, Boston, or California, Belgium’s KU Leuven University has topp...

Ivermectin, Dr Pierre Kory’s magic bullet to fight COVID-19

02 Mar 2021

Contributed by Lukas

Over the course of the summer, there was a vital discovery that severe, late stage COVID-19 which had been considered a near fatal condition could be ...

Ivor Cummins, “The Fat Emperor” Takes on COVID-19 Lockdowns

05 Feb 2021

Contributed by Lukas

If you’ve ever found yourself researching COVID-19 on YouTube, it’s likely you’ve stumbled onto a well-spoken Irishman named Ivor Cummins dissec...

PharmaCCX, a tech savvy solution for pricing EU cancer drugs

28 Jan 2021

Contributed by Lukas

The cost of new, highly targeted cancer therapies is becoming a serious political issue in the US, as it has been in Europe for many years. Europeans ...

BIO’s New CEO Michelle McMurry-Heath, Taking Charge Amidst Chaos

11 Dec 2020

Contributed by Lukas

Michelle McMurry-Heath assumed the leadership of the Biotechnology Innovation Organization (BIO) as President and CEO on June 1, 2020. A medical docto...

Heidi Larson – Dispelling Vaccine Myths in the COVID-19 Era

19 Nov 2020

Contributed by Lukas

With the recent announcement of Pfizer’s completion of clinical trials for a COVID-19 vaccine, the next challenge is ensuring that the general publi...

Hack Healthcare’s Leo Exter and Awell Health’s Thomas Vande Casteele

10 Nov 2020

Contributed by Lukas

What do you get when you have over 1000 technology developers, healthcare professionals, and medical practitioners working together on a specific prob...

Matt Wiener - EHDEN’s SME Marketplace and Harnessing Informatics

20 Oct 2020

Contributed by Lukas

Matt Wiener co-leads the development of EHDEN’s SME Marketplace, training and certifying the project’s growing international network of SMEs that ...

Kees van Bochove, A Hyve in EHDEN

12 Oct 2020

Contributed by Lukas

Kees van Bochove founded The Hyve, based in Utrecht, to facilitate open source software development, enable open science by developing and FAIRifying ...

«« ← Prev Page 2 of 2